Drugs for Rare Diseases

Funding Opportunity

In March 2024, we launched an open call for time-limited funding to help registry owners in Canada enhance and expand their registries to better support regulatory and reimbursement decision-making. More than 60 applicants submitted proposals, and 18 organizations were selected following a rigorous evaluation process.

Submissions were evaluated by ranking proposals that demonstrated the highest scores within domains, such as immediate impact, strategic importance, and feasibility, among other domains laid out in the RFP.

The following are the successful organizations.

Table 1: Funding Recipients 

Registry 

Lead applicants 

Awarded amount 

Canadian Acromegaly Registry; Lumiio Inc.  Dr. Victoria Hodgkinson  $191,250
Canadian Bleeding Disorder Registry (CBDR); McMaster University  Dr. Alfonso Iorio, Arun Keepanasseril  $199,456
Canadian Fabry Disease Initiative (CFDI) Registry; Nova Scotia Health Authority (NSHA)  Dr. Michael West, Kaye LeMoine  $148,915
Canadian Hereditary Angioedema Network (CHAEN); Canadian Hereditary Angioedema Registry (CHAER)  Peter Waite  $192,000
Canadian Inflammatory Myopathy Study Group (CIMS); Sir Mortimer B. Davis Jewish General Hospital (Lady Davis)  Dr. Valérie Leclair, Dr. Marie Hudson, and Dr. May Choi  $192,785
Canadian Pediatric Neuroinflammatory Disorders (CPND) Registry; Hospital for Sick Children (SickKids)  Dr. Ann Yeh  $199,750
Canadian Pulmonary Hypertension Registry (CPHR); University of British Columbia  Dr. John Swiston  $101,026
Canadian Registry for Rare Systemic Autoinflammatory Diseases (CAN-SAID Registry); University of British Columbia and Provincial Health Services Authority (PHSA)  Dr. Lori Tucker, Dr. Kelly Brown, and Dr. Quynh Doan  $198,949
Canadian Vasculitis Network Registry (CanVascR); Lawson Health Research Institute (LHRI)  Dr. Lillian Barra  $199,493
Children’s Hospital of Eastern Ontario Research Institute Inc. (CHEO RI); Canadian PKU Registry and Canadian MPS Registry  Dr. Pranesh Chakraborty  $198,640
Fighting Blindness Canada  Dr. Larissa Moniz  $110,880
Research Institute of MUHC (McGill University Health Centre); Canadian Morphea Registry (C-MORE)  Dr. Elena Netchiporouk  $200,000
The Canadian Alliance of Pediatric Rheumatology Investigators (CAPRI) Juvenile Idiopathic Arthritis (JIA) Registry and Pediatric Vasculitis Initiative (PedVas) and A Registry of Childhood Vasulitis (PedVas/ARChiVe); University of British Columbia;   Dr. David Cabral and Dr. Jaime Guzman  $195,207 
The Canadian Cystic Fibrosis Registry; Cystic Fibrosis Canada  Dr. Paul Eckford, Stephanie Cheng  $199,417 
University of British Columbia and Providence Health Care Society; Canadian Registry for Pulmonary Fibrosis (CARE-PF)  Dr. Christopher Ryerson  $172,350
University of Calgary; Canadian Neuromuscular Disease Registry (CNDR)  Dr. Lawrence Korngut, Dr. Victoria Hodgkinson, Dr. Megan Crone, Dr. Gordon Jewett, and Adrienna Marie Dyck  $124,906
University of Calgary; Canadian Registry for Amyloidosis Research (CRAR)  Dr. Nowell Fine and Dr. Margot Davis  $199,762
World Federation of Hemophilia Gene Therapy Registry; World Federation of Hemophilia  Donna Coffin  $200,000

How Funds Will Drive Quality Enhancements

The funds will support a diverse range of objectives aimed at enhancing registries, such as: 

  • technological infrastructure upgrades
  • enhancing registry policies and development of other key documents 
  • expanding data coverage
  • improving capabilities to support decision-grade analyses. 

This time-limited funding runs until March 31, 2025.

Read our corporate announcement.

Request for Proposal

This funding opportunity closed April 2024. The RFP document describes the scope of the funding opportunity, submission guidelines, application and funding process, and proposal evaluation and selection process.